Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
A Year of Ground-breaking Achievements in Organ Transplants at KFSHRC
Over 880 transplants including World-first robotic surgeries, solidify KFSHRC's position as a global leader RIYADH, Saudi Arabia, Jan.29, 2025(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) proudly celebrates a year of transformative achievements through its Organ Transplant Centre of Excellence (OTCoE). This reflects its leadership in healthcare innovation and dedication to improving patient lives as it prepares to highlight its groundbreaking...
Nasdaq GlobeNewswire
29/01/2025
Household Quotes Announces Rebrand To WhatCost
WhatCost: A clearer path to home improvement success WhatCost: A clearer path to home improvement success WhatCost reflects a commitment to helping homeowners find the best deals on their projects. The new name is clear and memorable, conveying their core service: We'll help you find the cost of your next home improvement project. Whether it's a traditional home improvement like a new kitchen or bathroom, or a more modern project like installing solar panels or a heat pump, WhatCost is...
PR Newswire
29/01/2025
Estonia Showcases Digital Health Leadership at Arab Health 2025
"Our fully integrated digital health system empowers every citizen with secure access to their online health records, seamlessly connecting data from healthcare providers across the nation. This initiative exemplifies how a collaborative approach between state-backed innovation and private sector expertise can revolutionize healthcare accessibility and enhance efficiency," says H.E. Maria Belovas, Ambassador of Estonia to UAE. "Our fully integrated digital health system empowers…
PR Newswire
29/01/2025
ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online…
ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platformsPartnership with Lovell Government Services is providing commercial benefit, facilitating purchase through validated US government online purchasing platforms EINDHOVEN, the Netherlands, Jan.29, 2025(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to...
Nasdaq GlobeNewswire
29/01/2025
Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of…
Algeness® is the culmination of many years of scientific and clinical research to define a novel biocompatible material to fill wrinkles and volume loss in facial soft tissues. Their team of scientists and physicians worked with Algeness® to create an exceptional 100% natural and biodegradable injectable implant with a unique injection technique. Algeness ®is the culmination of many years of scientific and clinical research to define a novel biocompatible material to fill wrinkles and volume...
PR Newswire
29/01/2025
Change to the Roche Enlarged Corporate Executive Committee
Wafaa Mamilli(1967) will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO,Thomas Schinecker, and will become a member of the enlarged Corporate Executive Committee starting 10 February 2025. She will be based at Genentech in South San Francisco.In this new role, she will take over the worldwide responsibility for the Informatics function for the Roche Group fromAlan Hippe, who currently has the dual role of Chief Financial Officer (CFO) and Chief...
Nasdaq GlobeNewswire
29/01/2025
Dry Eye Disease Market to Observe Stupendous Growth by 2034 | DelveInsight
Key Takeaways from the Dry Eye Disease Market Report Key Takeaways from the Dry Eye Disease Market Report Discover which therapies are expected to grab the major dry eye disease market share @ Dry Eye Disease Market Report Dry Eye Disease Overview Dry eye disease (DED) is a common chronic condition characterized by inadequate tear production or excessive tear evaporation, leading to inflammation and damage to the eye's surface. Causes of DED are multifactorial and include...
PR Newswire
28/01/2025
MolecuLight Announces Presentation of its Clinical and Surgical Benefits in…
As a Fellow of the American College of Surgeons (FACS), member of the American Society of Plastic Surgeons, and with expertise in hyperbaric medicine, Dr. Desvigne works alongside a multidisciplinary team at the Plastic & Reconstructive Surgery, Wound Care & Hyperbaric Medicine Department at Abrazo Arrowhead Hospital and Wound Clinic in Glendale, Arizona. The team includes affiliate hospitals and a diverse range of healthcare professionals such as wound care clinicians, hospitalists, ID…
PR Newswire
28/01/2025
Groupe Casino : Bilan du contrat de liquidité au 31 décembre 2024
CASINO, GUICHARD-PERRACHON Société anonyme au capital de 4 009 397,13 € Siège social : 1, Cours Antoine Guichard 42000 SAINT-ETIENNE 554 501 171 R.C.S. SAINT-ETIENNECommuniqué établissant le bilan semestriel du contrat de liquidité de la sociétéCASINO, GUICHARD-PERRACHON Au titre du contrat de liquidité confié par la société Casino, Guichard-Perrachon à Rothschild Martin Maurel, les moyens suivants figuraient au compte de liquidité à la date du31 décembre 2024: ...
Nasdaq GlobeNewswire
28/01/2025
Point of Care Diagnostics Market to Hit USD 22.63 Billion by 2029 with 8.5% CAGR…
Browse in-depth TOC on "Point of Care Diagnostics Market"778 - Tables59 - Figures564 - Pages Browse in-depth TOC on "Point of Care Diagnostics Market" 778 - Tables 59 - Figures 564 - Pages Advances such as miniaturized, transportable diagnostic devices, which present laboratory-quality findings outside of health care settings, represent a leading technological shift within the point of care diagnostics market. These small devices, largely based on new, advanced forms of...
PR Newswire
28/01/2025
Michter's Adds to Its Legacy Series With First Release of Bomberger's PFG™…
The Bomberger's PFG™ finishing barrel is a blend of wood from various origins, including the revered Tronçais, Allier, Nevers, and Vosges forests. It is constructed from wood that has been naturally air dried outdoors for a minimum of 40 months in France near the Charente River, which has a unique seasoning environment influenced by humidity, microflora creation, climate, wind direction, and elevation. After this seasoning, the staves are hand selected to construct the Bomberger's PFG™ finishing…
PR Newswire
28/01/2025
KFSHRC's DCEO Highlights Medical Tourism Growth at Arab Health 2025
Advanced Tech and Global Collaborations Attract Patients from 17 Countries RIYADH, Saudi Arabia, Jan.28, 2025(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) Deputy Chief Executive Officer, Dr. Björn Zoëga, represented KFSHRC at the region's premier healthcare event, Arab Health 2025, held recently in Dubai. Dr. Zoëga participated in a panel discussion titled “Investing in KSA's Healthcare Future”.The panel discussion emphasized KFSHRC's critical...
Nasdaq GlobeNewswire
28/01/2025
Spectra Medical, XL Precision Technologies Announce Rebrand as Elevaris Medical…
The Spectra acquisition of XLPT, announced in September 2024 by healthcare technology and services investor QHP Capital, brought together the companies' complementary strengths in servicing medical device manufacturers from large-scale Original Equipment Manufacturers (OEMs) to start-ups. Spectra has long been highly regarded for the expansive engineering and manufacturing capabilities and expert technical customer support it provides OEMs. XLPT is widely admired for its specialty manufacturing…
PR Newswire
28/01/2025
Next-generation Sequencing (NGS) Market to Hit USD 22.38 Billion by 2029 with…
Browse in-depth TOC on "Next-generation Sequencing (NGS) Market"620 - Tables51 - Figures570 - Pages Browse in-depth TOC on "Next-generation Sequencing (NGS) Market" 620 - Tables 51 - Figures 570 - Pages Based on Offerings,the market is divided into products and services segments. The products segment accounted for the largest share of the next-generation sequencing market in 2023. The large share of products in the NGS market is mainly attributed to the essential role…
PR Newswire
28/01/2025
Nine hours of scrolling: UAE's longest film shines light on the negative…
A recent internal data study from Tik Tok reveals that 95% of smartphone users under 17 are on the platform, with its algorithm often keeping kids up late and limiting real-world interactions. A recent survey from Dr. Alison Burrows, an expert in screen time, professor, and parent coach revealed that nearly 65% of parents believe their children spend too much time on screens A recent internal data study fromTik Tokreveals that 95% of smartphone users under 17 are on the platform, with its...
PR Newswire
28/01/2025
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
Tracking genomic variants across multiple time points in the same patient is becoming increasingly critical in cancer care, particularly for identifying treatment resistance or detecting residual cancer cells, such as in Measurable Residual Disease (MRD) management. The integration of longitudinal tracking capabilities with next-generation sequencing (NGS) allow the parallel detection of cancer-specific genetic mutations at very low frequencies. This combined approach enables early…
PR Newswire
28/01/2025
Jiva Technologies Announces the Launch of www.LIV3Health.com, Kicking Off…
The launch of www.LIV3Health.com is not just a digital storefront; it is the result of a highly collaborative effort between Jiva Technologies and LIV3's leadership team, blending state-of-the-art design with a user-centric experience. By providing a seamless online interface, the new website sets the stage for comprehensive influencer marketing campaigns and effective lead generation, aimed at cultivating a robust customer base well before the product hits the market. The launch of www...
PR Newswire
28/01/2025
Evaxion granted 180-day compliance extension by Nasdaq as it restores equity…
Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to the Nasdaq minimum equity requirementEvaxion has currently restored its equity above the minimum requirement through exercise of prefunded warrants and sales through its ATM-facility providing $7.8 million, extending its cash runway until Q4 2025The conversion of Evaxion's EIB-loan to equity is still expected to be completed in Q1, 2025, which is expected to...
Nasdaq GlobeNewswire
28/01/2025
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
A live webcast and archived replay of the Company's presentation can be accessed under “Events and Presentations” in theInvestor & Media Relationssection of the Zenas BioPharmawebsite. About Zenas BioPharma, Inc. Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team...
Nasdaq GlobeNewswire
28/01/2025
EQT Life Sciences leads USD 75 million Series B in Atalanta Therapeutics, a…
Alicia Secor, M.B.A., Atalanta's President and Chief Executive Officer, said: "We're excited by the support we've received from this strong group of investors, led by EQT Life Sciences. This Series B will support a path to the clinic for two programs for serious neurological diseases that today lack disease-modifying therapies: KCNT1-related epilepsy and Huntington's disease. We're diligently progressing these medicines toward IND submissions next year so that we can start our Phase 1…
PR Newswire
28/01/2025
Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with…
By combining data and information from the global pricing and market access platform, NAVLIN by EVERSANA®, with Lyfegen's Public Drug Agreement Library, the two organizations will harness cutting-edge AI to empower market access and pricing professionals with actionable insights. The joint agreement marks a key step in tackling rising drug costs and improving patient access globally. By combining data and information from the global pricing and market access platform,NAVLIN by EVERSANA ...
PR Newswire
28/01/2025
AeroFlexx and Chemipack Launch Partnership to Drive Packaging Innovation and…
"AeroFlexx's technology is set to meet the industry demand for innovative packaging throughout Europe," said Chemipack Sp. z o.o. Chairman and CEO, Robert Serafiński. "This partnership with AeroFlexx will drive the growing momentum for more eco-friendly packaging in Europe and accelerate the transition to more sustainable practices in the packaging space globally." "AeroFlexx's technology is set to meet the industry demand for innovative packaging throughoutEurope,"…
PR Newswire
28/01/2025
ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11, a…
Phase 3 clinical trial with ITM-11 met its primary endpoint, demonstrating clinically relevant and statistically significant benefit in Progression-Free Survival (PFS) compared to everolimusITM plans to submit the COMPETE data for presentation at a future medical conference, with potential US regulatory submission anticipated in 2025ITM continues to advance a broad clinical pipeline, with multiple assets being investigated across seven different tumor types, including glioblastoma and...
Nasdaq GlobeNewswire
28/01/2025
Curium Further Expands European Availability of PYLCLARI – an Innovative…
®is now available for patients with prostate cancer. PYLCLARI® (INN: Piflufolastat ( 18 F) also known as ( 18 F)-DCFPyL) is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in patients with prostate cancer in the following clinical settings: Primary staging of patients with high-risk prostate cancer prior to initial curative therapyTo localize recurrence of prostate cancer in patients with a suspected...
Nasdaq GlobeNewswire
28/01/2025
Altri Comunicati